Children News and Research

RSS

The April 2004 issue of Otolaryngology focuses on head and neck surgery

The efficacy of a new cancer-fighting virus is tested in the study, “Treatment of Solid Sarcomas in Immunocompetent Mice with Novel Oncolytic Herpes Simplex Viruses.” A team of multi-disciplinary Japanese researchers found that a weakened version of herpes simplex virus (HSV) effectively eradicated neck and flank tumors in mice.

23 Apr 2004

Focusing on soft drinks is the next logical step in the war against pediatric obesity

According to a year-long study of 644 children aged between 7 and 11 in six primary schools in Christchurch, England – outlined this week on the website of the British Medical Journal – a one-year campaign to curb soft drink intake led to a decrease in the percentage of those children who were overweight or obese.

23 Apr 2004

Certain cells from a mother can cause immunity illness in children

Certain cells from a mother persist in their children’s bodies and can provoke an immune response in which the child’s body attacks itself, according to Mayo Clinic research published in the current issue of the Journal of Immunology (http://www.jimmunol.org).

23 Apr 2004

GSK and WHO collaborate to fight malaria

GlaxoSmithKline (GSK), the World Health Organisation's Special Programme for Research and Training in Tropical Diseases (WHO-TDR) and the Medicines for Malaria Venture (MMV) today announced the signing of a collaborative agreement, to develop a new-fixed dose artemisinin combination therapy drug (ACT), combining chlorproguanil, dapsone and artesunate (CDA) for the treatment of malaria.

23 Apr 2004

Avoid feeding infants fluoridated water, researchers caution

Infant formulas prepared with fluoridated water increase dental fluorosis risk, according to the April 2004 Journal of the American College of Nutrition(1) and other studies. To prevent this tooth staining, researchers caution against mixing infant formulas with fluoridated water.

23 Apr 2004

SSRI antidepressants may be unsuitable for children

A UK study in this week's issue of THE LANCET suggests that reliance on published studies alone to guide the treatment of childhood depression could be inappropriate. A systematic review including published and unpublished data shows that only one drug, fluoxetine (Prozac), was not associated with negative outcomes for children with depression.

22 Apr 2004

Research into link between oceans and human health

The National Science Foundation (NSF) and the National Institute of Environmental Health Sciences (NIEHS), one of the National Institutes of Health, have announced funding for four joint Centers for Oceans and Human Health (COHH). The centers will be located at the University of Washington, the University of Hawaii, the Woods Hole Oceanographic Institution in Massachusetts, and the University of Miami.

22 Apr 2004

Access to effective malaria treatment for Africa threatened by drug shortages

Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.

22 Apr 2004

HHS approves first-ever multi-state purchasing pools for Medicaid drug programs

HHS Secretary Tommy G. Thompson today approved plans by five states to pool their collective purchasing power to gain deeper discounts on prescription medicines for their state programs.

22 Apr 2004

Third Melbourne hospital infected by Serratia bacteria

A spokeswoman for The Royal Women's Hospital says three babies so far have been isolated after they were found to be carrying the serratia bacteria.

22 Apr 2004

Clinical trial of curcumin in people with cystic fibrosis

Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the nonprofit drug discovery and development affiliate of the Cystic Fibrosis Foundation, today announced that it is funding a clinical trial of curcumin in people with cystic fibrosis (CF).

22 Apr 2004

Fizzy drinks cause obesity in children

Discouraging children from drinking fizzy drinks can prevent excessive weight gain, according to new research available on bmj.com.

22 Apr 2004

WHO renews call for effective malaria treatment

More than 600 million people, most of them children living in sub-Saharan Africa, face the daily threat of death from malaria because new, effective treatments are not available where they live. Existing, cheaper medicines, which have been used for many years, are no longer effective in most places because the malaria parasite has developed resistance to them.

22 Apr 2004

FDA approval for drug to treat attention deficit hyperactivity disorder

McNeil Consumer & Specialty Pharmaceuticals has received an approvable letter from the U.S. Food and Drug Administration (FDA) for the use of CONCERTA® (methylphenidate HCl) CII Extended-release Tablets in adolescents with Attention Deficit/Hyperactivity Disorder (ADHD) and to expand labeling to include a 72 mg dosing regimen.

22 Apr 2004

Adult ADHD screening in New York

Despite wide recognition as a children’s disorder, ADHD (Attention-Deficit/Hyperactivity Disorder) affects millions of adults who are undiagnosed and untreated.

22 Apr 2004

Expert calls for standard epinephrine doses when treating children in cardiac arrest

Medical personnel attempting to resuscitate a child in cardiac arrest should abide by epinephrine dosing levels outlined in the Pediatric Advanced Life Support (PALS) guidelines rather than giving larger amounts of the drug, says a nationally recognized pediatrician from UT Southwestern Medical Center at Dallas.

22 Apr 2004

Fish oil reduces heart attack and blood vessel disease

Fish oil can help reduce deaths from heart disease, according to new evidence reports announced today by the Agency for Healthcare Research and Quality.

22 Apr 2004

Supplements help prevent cavities in children where water quality and fluoride content is poor

Primary care clinicians who practice in areas where the water supply is deficient in fluoride should prescribe oral fluoride supplements to preschool children over the age of 6 months, according to a recommendation from the U.S. Preventive Services Task Force.

22 Apr 2004

FDA approves Advair Diskus® for children with asthma

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) approved the use of Advair 100/50 in children four years to eleven years of age with asthma who are symptomatic on inhaled corticosteroid therapy alone.

22 Apr 2004

Prediction of adult diseases in infancy

A new way of predicting which young children are most at risk of eventually contracting diabetes and heart disease in adult life is being developed by researchers at Cambridge University - with help from Bristol’s Children of the 90s.

22 Apr 2004